Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Solubilization and purification of HBx protein core segment in HBV and monoclonal antibody

A monoclonal antibody and protein technology, applied in the direction of immunoglobulin, chemical instruments and methods, antiviral immunoglobulin, etc., can solve the problems of inability to produce and prepare protein preparations on a large scale, precipitation, and influence on HBx interaction

Inactive Publication Date: 2019-10-18
FUDAN UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the protein samples obtained by combining these fusion proteins with HBx have the following disadvantages: the concentration usually can only reach about 1 mg / ml, HBx will precipitate immediately after the fusion protein is cut off by the enzyme, and larger fusion proteins may affect HBx and other proteins , nucleic acid interactions
[0006] A method for solubilizing and purifying HBxΔNΔC is reported in the published literature. The HBxΔNΔC obtained by this method is highly soluble in the solution, but the obtained HBxΔNΔC sample is unstable, easily degraded, inhomogeneous, not high enough in purity, and not functional. Stablize( figure 1 ), it is impossible to produce and prepare active, stable, high-uniformity, and high-purity protein preparations on a large scale. It is only suitable for small-scale laboratory research and has no commercial application prospects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solubilization and purification of HBx protein core segment in HBV and monoclonal antibody
  • Solubilization and purification of HBx protein core segment in HBV and monoclonal antibody
  • Solubilization and purification of HBx protein core segment in HBV and monoclonal antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1, Solubilization and purification of HBxΔNΔC.

[0031] In the present invention, the HBxΔNΔC sequence is cloned on the pet15b expression vector, Nco1 and Xho1 enzyme cutting sites are selected, and the N-terminal 6XHis on the vector is reserved for subsequent purification work.

[0032] In the present invention, the prokaryotic cell expression system of Escherichia coli is preferred (but other expression systems are not excluded, such as expression in other bacteria or other eukaryotic cells); the above-mentioned proteins are expressed in the form of inclusion body proteins , the His tag is preferred (but other tags, such as MBP, GST or SUMO tags are not excluded).

[0033] Specifically, the present invention transforms the plasmid containing the HBxΔNΔC sequence into Escherichia coli Rosetta strains (other Escherichia coli expression strains are not excluded) for recombinant expression, obtains HBxΔNΔC inclusion bodies, and then purifies. The specific steps ar...

Embodiment 2

[0042] Example 2, preparation of murine HBxΔNΔC monoclonal antibody.

[0043] The present invention uses the obtained active HBxΔNΔC as an antigen to prepare mouse-derived HBxΔNΔC monoclonal antibodies, and obtains two hybridoma cell lines that can stably produce mouse-derived HBxΔNΔC monoclonal antibodies. The specific steps for preparing mouse HBxΔNΔC monoclonal antibody are as follows:

[0044] (1) Using the active HBxΔNΔC obtained by the aforementioned purification method as an antigen, immunize 3 Balb / C mice;

[0045] (2) One mouse with high titer is selected for each project for fusion, and each mouse is fused with 10 96-well plates and clone screening experiments;

[0046] (3) Replace the positive background with the supernatant after fusion, perform ELISA screening for immune proteins after 2-3 days of culture, select all positive clones and expand them into 24-well cell culture for culture, and test and verify the supernatant of each clone;

[0047] (4) The confirme...

Embodiment 3

[0050] Example 3. Preparation of other animal-derived or humanized HBxΔNΔC monoclonal antibodies.

[0051] Using active HBxΔNΔC as an antigen, any animal-derived HBxΔNΔC monoclonal antibody can be obtained in other animals through the monoclonal antibody preparation method.

[0052] Humanized HBxΔNΔC monoclonal antibodies can be obtained by using animal-derived HBxΔNΔC monoclonal antibodies according to general antibody humanization methods.

[0053] The above monoclonal antibodies can be applied to scientific research targeting HBx protein, and as diagnostic reagents for detection and treatment of diseases caused by HBV virus infection. Humanized monoclonal antibodies can also be directly applied to human body as auxiliary preparations for treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of a biological technology, and particularly relates to a purification method of an HBx protein core segment HBx delta N delta C in HBV and an HBx delta N delta C monoclonal antibody. A formula and purification process of various buffered solutions in an original purification method are changed, so that HBx delta N delta C samples being active, stable, uniform, high in purity and solitary are obtained, and standard large-scale production and preparation are convenient. The obtained HBx delta N delta C are used for further preparing a mouse sourced HBx delta Ndelta C monoclonal antibody and hybridoma strains which can stably express the mouse sourced HBx delta N delta C monoclonal antibody. The HBx delta Ndelta C and the HBx delta N delta C monoclonal antibody can be used as a scientific research reagent, the mouse sourced HBx delta N delta C monoclonal antibody can also be used as a detection reagent of hepatitis b virus HBV infection diseases, and the mouse sourced HBx delta N delta C monoclonal antibody is humanized, so that humanized HBx delta N delta C monoclonal antibody can be obtained and can be used as a scientific research reagent, a detection reagent for HBV infection diseases and an auxiliary treatment preparation.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a method for solubilization and purification of the HBx protein core segment HBxΔNΔC in hepatitis B virus (HBV), and an HBxΔNΔC monoclonal antibody. Background technique [0002] The renaturation method of inclusion body protein is a traditional method for solubilizing inclusion body protein. This method first uses high concentration denaturant to solubilize the inclusion body protein, for example, use a buffer containing 8 M urea or 6 M thiourea to dissolve the inclusion body protein. Afterwards, through the process of removing the high-concentration denaturant, the inclusion body protein is refolded from a denatured state to a soluble state, such as using buffer dialysis without a denaturant to remove the denaturant, so that the inclusion body protein is refolded soluble. Due to the lack of understanding of the process and rules of protein folding and renaturation, th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/70C07K14/02C07K1/36C07K1/34C07K1/22C07K1/14C07K16/08
CPCC12N15/70C07K14/005C07K16/082C12N2730/10122C07K2317/24
Inventor 胡小健祁祺李龙王森
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products